<VariationArchive VariationID="2426153" VariationName="NC_000007.13:g.(?_124491926)_(124537227_?)del" VariationType="Deletion" Accession="VCV002426153" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2023-02-13" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1951557" VariationID="2426153">
      <GeneList>
        <Gene Symbol="POT1" FullName="protection of telomeres 1" GeneID="25913" HGNC_ID="HGNC:17284" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q31.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="124822386" stop="124929825" display_start="124822386" display_stop="124929825" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="124462439" stop="124570036" display_start="124462439" display_stop="124570036" Strand="-" />
          </Location>
          <OMIM>606478</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000007.13:g.(?_124491926)_(124537227_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q31.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" innerStart="124491926" innerStop="124537227" display_start="124491926" display_stop="124537227" variantLength="45302" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.(?_124491926)_(124537227_?)del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.(?_124491926)_(124537227_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000007.13:g.(?_124491926)_(124537227_?)del AND Tumor predisposition syndrome 3" Accession="RCV003119591" Version="4">
        <ClassifiedConditionList TraitSetID="16369">
          <ClassifiedCondition DB="MedGen" ID="C4014476">Tumor predisposition syndrome 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-21" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">32155570</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="16369" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="21232" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Melanoma, cutaneous malignant, susceptibility to, 10</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">LONG TELOMERE SYNDROME, POT1-RELATED</ElementValue>
                <XRef Type="MIM" ID="615848" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tumor predisposition syndrome 3</ElementValue>
                <XRef ID="MONDO:0014368" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glioma susceptibility 9</ElementValue>
                <XRef ID="MONDO:0014695" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TPDS3</ElementValue>
                <XRef Type="MIM" ID="615848" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CMM10</ElementValue>
                <XRef Type="MIM" ID="615848" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GLM9</ElementValue>
                <XRef Type="MIM" ID="615848" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">POT1 tumor predisposition (POT1-TPD) is characterized by an increased lifetime risk for multiple cutaneous melanomas, chronic lymphocytic leukemia (CLL), angiosarcoma (particularly cardiac angiosarcomas), and gliomas. Additional cancers (e.g., colorectal cancer, thyroid cancer, breast angiosarcomas) have been reported in individuals with POT1-TPD but with very limited evidence. The age of onset for first primary cutaneous melanoma ranges from 15 to 80 years. The majority of POT1 associated cancers are diagnosed in adulthood.</Attribute>
                <XRef ID="NBK563529" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18582" />
                <XRef ID="18582" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33119245</ID>
                <ID Source="BookShelf">NBK563529</ID>
              </Citation>
              <XRef ID="618" DB="Orphanet" />
              <XRef ID="C4014476" DB="MedGen" />
              <XRef ID="MONDO:0014368" DB="MONDO" />
              <XRef Type="MIM" ID="615848" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7075087" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_015450.2_Deletion (Exons 5-11)|MedGen:C4014476" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003794042" DateUpdated="2023-11-11" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32155570</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 5-11 of the POT1 gene, which includes the initiator codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POT1 are known to be pathogenic (PMID: 32155570). This variant has not been reported in the literature in individuals affected with POT1-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.(?_124491926)_(124537227_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4014476" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7075087" TraitType="Disease" MappingType="XRef" MappingValue="C4014476" MappingRef="MedGen">
        <MedGen CUI="C4014476" Name="Tumor predisposition syndrome 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

